Sex Differences in Dopamine Receptor Signaling in <i>Fmr1</i> Knockout Mice: A Pilot Study
Fragile X syndrome (FXS) is an X-chromosome-linked dominant genetic disorder that causes a variable degree of cognitive dysfunction and developmental disability. Current treatment is symptomatic and no existing medications target the specific cause of FXS. As with other X-linked disorders, FXS manif...
Guardado en:
Autores principales: | Anlong Jiang, Le Wang, Justin Y. D. Lu, Amy Freeman, Charlie Campbell, Ping Su, Albert H. C. Wong, Fang Liu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4d31ac84f8ca48baabd3a110d5c4cedf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Beyond Trinucleotide Repeat Expansion in Fragile X Syndrome: Rare Coding and Noncoding Variants in <i>FMR1</i> and Associated Phenotypes
por: Cedrik Tekendo-Ngongang, et al.
Publicado: (2021) -
Altered expression of fragile X mental retardation-1 (FMR1) in the thymus in autoimmune myasthenia gravis
por: Scott Thomas, et al.
Publicado: (2021) -
Tamizaje clínico y análisis de mutaciones en el gen FMR1 en 99 varones con características clínicas del síndrome de X-frágil
por: Alliende R,M. Angélica, et al.
Publicado: (2006) -
Fragile X Syndrome and Targeted Treatments
por: Nattaporn Tassanakijpanich, et al.
Publicado: (2020) -
NMD abnormalities during brain development in the Fmr1-knockout mouse model of fragile X syndrome
por: Tatsuaki Kurosaki, et al.
Publicado: (2021)